Rabies Vaccine (Human Diploid Cell)
Establishment time : 1967
website : www.sanofipasteur.com
Main Product : Rabies Vaccine (Human Diploid Cell)
Company Profile
Sanofi Pasteur is a leading pharmaceutical company specializing in vaccines. Established in 1967, the company has a strong presence in the global market and is known for its high-quality rabies vaccine produced using human diploid cells. With a large company size and a dominant position in the market, Sanofi Pasteur continues to innovate and provide essential vaccines to protect public health worldwide.
Rabipur
Establishment time : 1989
website : www.rabipur.com
Main Product : Rabies vaccine
Company Profile
Rabipur is a renowned pharmaceutical company specializing in the production of rabies vaccines. Established in 1989, Rabipur has grown to become a global leader in the field, providing high-quality vaccines to prevent rabies infections worldwide. With a large presence in the market, Rabipur is known for its commitment to excellence and innovation in vaccine development.
Purified Vero Cell Rabies Vaccine (PVRV)
Establishment time : Sanofi Pasteur is a global healthcare company focused on preventing infectious diseases through vaccines.
website :
Main Product : One of their main products is the Purified Vero Cell Rabies Vaccine (PVRV), which is highly effective in preventing rabies.
Company Profile
Overall, Sanofi Pasteur is a trusted and reliable source for high-quality vaccines, including the PVRV.
Inactivated Rabies Vaccine (IRV)
Establishment time : Sanofi Pasteur is a global leader in vaccines, with a long history of providing high-quality products to protect against infectious diseases.
website :
Main Product : With a large presence in the global market, Sanofi Pasteur's IRV is widely used in both developed and developing countries.
Company Profile
Sanofi Pasteur continues to invest in new technologies and partnerships to improve the availability and accessibility of their vaccines, including the Inactivated Rabies Vaccine.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Rabies Vaccine BP
Establishment time : 1987
website :
Main Product : Rabies vaccine
Company Profile
Rabies Vaccine BP is a small pharmaceutical company established in 1987, specializing in the production of rabies vaccines. With a focus on the local market, the company faces limited competition in providing essential vaccines for the prevention of rabies.
May 28, 2024
